2014 Strategies for the Spanish HIV/AIDS Diagnostics Testing Market
US$ 1,840.00
... . Profiles leading manufacturers and potential market entrants developing innovative technologies and products. Analyzes alternative market penetration strategies for suppliers. Methodology The report is based on a combination of primary and secondary information sources, including Venture Planning ...
January 2014
250 pages
2014 Strategies for the UK HIV/AIDS Diagnostics Testing Market
US$ 1,840.00
... . Profiles leading manufacturers and potential market entrants developing innovative technologies and products. Analyzes alternative market penetration strategies for suppliers. Methodology The report is based on a combination of primary and secondary information sources, including Venture Planning ...
January 2014
251 pages
2014 Strategies for the Global HIV/AIDS Diagnostic Testing Market
US$ 4,360.00
... leading suppliers and recent market entrants developing innovative technologies and products and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns. Contains 292 pages and 36 tables
January 2014
292 pages
2014 Strategies for the French Hemostasis Diagnostic Testing Market
US$ 4,880.00
... and business expansion opportunities with significant market appeal. 'Ideal' product models with tentative prices and operating characteristics. Alternative market penetration strategies for instrument and reagent suppliers. Potential market entry barriers and risks. Contains 405 pages and 35 tables
January 2014
405 pages
2014 Strategies for the German Hemostasis Diagnostic Testing Market
US$ 4,880.00
... and business expansion opportunities with significant market appeal. 'Ideal' product models with tentative prices and operating characteristics. Alternative market penetration strategies for instrument and reagent suppliers. Potential market entry barriers and risks. Contains 406 pages and 38 tables
January 2014
406 pages
2014 Strategies for the Italian Hemostasis Diagnostic Testing Market
US$ 4,880.00
... and business expansion opportunities with significant market appeal. 'Ideal' product models with tentative prices and operating characteristics. Alternative market penetration strategies for instrument and reagent suppliers. Potential market entry barriers and risks. Contains 402 pages and 35 tables
January 2014
402 pages
2014 Strategies for the Japanese Hemostasis Diagnostic Market
US$ 5,920.00
... and business expansion opportunities with significant market appeal. 'Ideal' product models with tentative prices and operating characteristics. Alternative market penetration strategies for instrument and reagent suppliers. Potential market entry barriers and risks. Contains 402 pages and 35 tables
January 2014
402 pages
2014 Strategies for the Spanish Hemostasis Diagnostic Testing Market
US$ 4,880.00
... and business expansion opportunities with significant market appeal. 'Ideal' product models with tentative prices and operating characteristics. Alternative market penetration strategies for instrument and reagent suppliers. Potential market entry barriers and risks. Contains 400 pages and 37 tables
January 2014
400 pages
2014 Strategies for the UK Hemostasis Diagnostic Testing Market
US$ 4,880.00
... and business expansion opportunities with significant market appeal. 'Ideal' product models with tentative prices and operating characteristics. Alternative market penetration strategies for instrument and reagent suppliers. Potential market entry barriers and risks. Contains 409 pages and 35 tables
January 2014
409 pages
2014 Strategies for the US Hemostasis Diagnostic Testing Market
US$ 7,680.00
... and business expansion opportunities with significant market appeal. 'Ideal' product models with tentative prices and operating characteristics. Alternative market penetration strategies for instrument and reagent suppliers. Potential market entry barriers and risks. Contains 424 pages and 37 tables
January 2014
424 pages
2014 Strategies for the French Microbiology Testing Market
US$ 5,360.00
... DataPack (test volumes, sales forecasts, supplier shares) $4,300. '2014 Strategies for the French Microbiology Testing Market' is a new strategic analysis of major ... market during the next five years. The report examines key French market trends; reviews current and emerging assays; analyzes potential ...
January 2014
890 pages
2014 Strategies for the German Microbiology Testing Market
US$ 5,360.00
... . DataPack (test volumes, sales forecasts, supplier shares) $4,300. '2014 Strategies for the German Microbiology Testing Market' is a new strategic analysis of major ... market during the next five years. The report examines key German market trends; reviews current and emerging assays; analyzes potential ...
January 2014
983 pages
2014 Strategies for the Italian Microbiology Testing Market
US$ 5,360.00
... DataPack (test volumes, sales forecasts, supplier shares) $4,300. '2014 Strategies for the Italian Microbiology Testing Market' is a new strategic analysis of major ... market during the next five years. The report examines key Italian market trends; reviews current and emerging assays; analyzes potential ...
January 2014
970 pages
2014 Strategies for the Japanese Microbiology Testing Market
US$ 7,040.00
... DataPack (test volumes, sales forecasts, supplier shares) $5,700. '2014 Strategies for the Japanese Microbiology Testing Market' is a new strategic analysis of major ... market during the next five years. The report examines key Japanese market trends; reviews current and emerging assays; analyzes potential ...
January 2014
976 pages
2014 Strategies for the Spanish Microbiology Testing Market
US$ 5,360.00
... DataPack (test volumes, sales forecasts, supplier shares) $4,300. '2014 Strategies for the Spanish Microbiology Testing Market' is a new strategic analysis of major ... market during the next five years. The report examines key Spanish market trends; reviews current and emerging assays; analyzes potential ...
January 2014
960 pages
2014 Strategies for the UK Microbiology Testing Market
US$ 5,360.00
Complete report $6,700. DataPack (test volumes, sales forecasts, supplier shares) $4,300. '2014 Strategies for the UK Microbiology Testing Market' is a new strategic analysis of major business opportunities emerging in the infectious disease testing market during the next five years. The report ...
January 2014
978 pages
2014 Strategies for the US Microbiology Testing Market
US$ 7,880.00
Complete report $9,850. DataPack (test volumes, sales forecasts, supplier shares) $6,400. '2014 Strategies for the US Microbiology Testing Market' is a new strategic analysis of major business opportunities emerging in the infectious disease testing market during the next five years. The report ...
January 2014
1037 pages
2014 Strategies for the Global Nucleic Acid Testing Market
US$ 25,760.00
... corporate strategies will be one of the most challenging tasks for diagnostic companies during the next ten years. Geographic Coverage France Germany ... years. Design criteria for new products. Alternative market penetration strategies. Potential market entry barriers and risks. Business planning issues ...
January 2014
1050 pages
2014 Strategies for the Global Orthopedics Market
US$ 3,880.00
... regions, including U.S., Europe, Japan/Pacific and others. The company profiles include: Business, new product development and marketing strategies. Anticipated acquisitions and joint ventures. Major strengths and weaknesses. The U.S. and international sales force size. Distribution approaches. Major ...
January 2014
136 pages
2014 Strategies for the Global Tumor Marker Testing Market: US, Europe, Japan
US$ 26,000.00
... major tumor markers by country and market segment Profiles leading market players and potential entrants Suggests alternative business expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs ...
January 2014
1200 pages
French Hospital Coagulation Testing Market 2014
US$ 3,120.00
... contains 398 pages, 29 tables, and presents a comprehensive analysis of the French hospital coagulation testing market, including: Major issues pertaining to the ... economic, regulatory, demographic, social and technological trends with significant market impact during the next five years. Volume and sales ...
January 2014
398 pages
German Hospital Coagulation Testing Market 2014
US$ 3,120.00
... contains 394 pages, 28 tables, and presents a comprehensive analysis of the German hospital coagulation testing market, including: Major issues pertaining to the ... economic, regulatory, demographic, social and technological trends with significant market impact during the next five years. Volume and sales ...
January 2014
394 pages
Italian Hospital Coagulation Testing Market 2014
US$ 3,120.00
... contains 394 pages, 28 tables, and presents a comprehensive analysis of the Italian hospital coagulation testing market, including: Major issues pertaining to the ... economic, regulatory, demographic, social and technological trends with significant market impact during the five five years. Volume and sales ...
January 2014
394 pages
Japanese Hospital Coagulation Testing Market 2014
US$ 3,880.00
... contains 392 pages, 28 tables, and presents a comprehensive analysis of the Japanese hospital coagulation testing market, including: Major issues pertaining to the ... economic, regulatory, demographic, social and technological trends with significant market impact during the next five years. Volume and sales ...
January 2014
392 pages
Spanish Hospital Coagulation Testing Market 2014
US$ 3,120.00
... contains 390 pages, 28 tables, and presents a comprehensive analysis of the Spanish hospital coagulation testing market, including: Major issues pertaining to the ... economic, regulatory, demographic, social and technological trends with significant market impact during the next five years. Volume and sales ...
January 2014
390 pages
UK Hospital Coagulation Testing Market 2014
US$ 3,120.00
... Group contains 402 pages, 28 tables, and presents a comprehensive analysis of the UK hospital coagulation testing market, including: Major issues pertaining to the ... economic, regulatory, demographic, social and technological trends with significant market impact during the next five years. Volume and sales ...
January 2014
402 pages
French Hospital Tumor Marker Testing Market 2014
US$ 3,080.00
... 533 pages, 43 tables, and presents a comprehensive analysis of the French hospital tumor marker testing market, including: Major issues pertaining to the ... , oral, skin and others. Test volume and sales forecasts for 40 tumor markers performed in French hospitals. Current instrumentation technologies and ...
January 2014
533 pages
German Hospital Tumor Marker Testing Market 2014
US$ 3,080.00
... 530 pages, 40 tables, and presents a comprehensive analysis of the German hospital tumor marker testing market, including: Major issues pertaining to the ... , oral, skin and others. Test volume and sales forecasts for 40 tumor markers performed in German hospitals. Current instrumentation technologies and ...
January 2014
530 pages
Italian Hospital Tumor Marker Testing Market 2014
US$ 3,080.00
... 525 pages, 38 tables, and presents a comprehensive analysis of the Italian hospital tumor marker testing market, including: Major issues pertaining to the ... , oral, skin and others. Test volume and sales forecasts for 40 tumor markers performed in Italian hospitals. Current instrumentation technologies and ...
January 2014
525 pages
Japanese Hospital Tumor Marker Testing Market 2014
US$ 3,880.00
... 537 pages, 42 tables, and presents a comprehensive analysis of the Japanese hospital tumor marker testing market, including: Major issues pertaining to the ... , oral, skin and others. Test volume and sales forecasts for 40 tumor markers performed in Japanese hospitals. Current instrumentation technologies and ...
January 2014
537 pages
Spanish Hospital Tumor Marker Testing Market 2014
US$ 3,080.00
... 521 pages, 41 tables, and presents a comprehensive analysis of the Spanish hospital tumor marker testing market, including: Major issues pertaining to the ... , oral, skin and others. Test volume and sales forecasts for 40 tumor markers performed in Spanish hospitals. Current instrumentation technologies and ...
January 2014
521 pages
UK Hospital Tumor Marker Testing Market 2014
US$ 3,080.00
This new report from Venture Planning Group contains 527 pages, 37 tables, and presents a comprehensive analysis of the UK hospital tumor marker testing market, including: Major issues pertaining to the UK hospital laboratory practice, as well as key economic, ...
January 2014
527 pages
US Hospital Tumor Marker Testing Market 2014
US$ 5,200.00
This new report from Venture Planning Group contains 567 pages, 50 tables, and presents a comprehensive analysis of the US hospital tumor market ... , testicular, oral, skin and others. Test volume and sales forecasts for 40 tumor markers performed in US hospitals. Current instrumentation technologies and ...
January 2014
567 pages
Sexually-Transmitted Diseases in Italy 2014: Market Outlook and Emerging Opportunities
US$ 1,560.00
About This Report This new 280-pages report from Venture Planning Group presents detailed analysis of the Italian STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis. The report provides test volume ...
January 2014
280 pages
Sexually-Transmitted Diseases in Japan 2014: Market Outlook and Emerging Opportunities
US$ 1,920.00
About This Report This new 280-page report from Venture Planning Group presents detailed analysis of the Japanese STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis. The report provides test volume ...
January 2014
280 pages
Sexually-Transmitted Diseases in Spain 2014: Market Outlook and Emerging Opportunities
US$ 1,560.00
About This Report This new 280-page report from Venture Planning Group presents detailed analysis of the Spanish STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis. The report provides test volume ...
January 2014
280 pages
Enteric Diseases in France 2014: Market Outlook and Emerging Opportunities
US$ 1,760.00
About This Report This new 322-page report from Venture Planning Group presents detailed analysis of the French Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia. ...
January 2014
322 pages
Enteric Diseases in Germany 2014: Market Outlook and Emerging Opportunities
US$ 1,760.00
About This Report This new 322-page report from Venture Planning Group presents detailed analysis of the German Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia. ...
January 2014
322 pages
Enteric Diseases in Italy 2014: Market Outlook and Emerging Opportunities
US$ 1,760.00
About This Report This new 322-page report from Venture Planning Group presents detailed analysis of the Italian Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia. ...
January 2014
322 pages
Enteric Diseases in Japan 2014: Market Outlook and Emerging Opportunities
US$ 2,080.00
About This Report This new 322-page report from Venture Planning Group presents detailed analysis of the Japanese Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia ...
January 2014
322 pages
Enteric Diseases in Spain 2014: Market Outlook and Emerging Opportunities
US$ 1,760.00
About This Report This new 322-page report from Venture Planning Group presents detailed analysis of the Spanish Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia. ...
January 2014
322 pages
Enteric Diseases in the UK 2014: Market Outlook and Emerging Opportunities
US$ 1,760.00
About This Report This new 322-page report from Venture Planning Group presents detailed analysis of the UK Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia. The ...
January 2014
322 pages
Enteric Diseases in the US 2014: Market Outlook and Emerging Opportunities
US$ 3,080.00
About This Report This new 322-page report from Venture Planning Group presents detailed analysis of the US Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia. The ...
January 2014
322 pages
Respiratory Diseases in France 2014: Market Outlook and Emerging Opportunities
US$ 1,560.00
About This Report This new 282-page report from Venture Planning Group presents detailed analysis of the French Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides ...
January 2014
282 pages
Respiratory Diseases in Germany 2014: Market Outlook and Emerging Opportunities
US$ 1,560.00
About This Report This new 283-page report from Venture Planning Group presents detailed analysis of the German Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides ...
January 2014
283 pages
